The Pharma Data

JULY 2, 2025

A Legacy of Legal and Strategic Excellence: Farewell to Birgitte Stephensen Birgitte Stephensen joined Genmab in 2002 , just three years after the company was founded. Over her impressive 23-year tenure , she played a pivotal role in shaping Genmab’s legal infrastructure during a period of remarkable growth and transformation.

Compliance

Common Sense for Drug Policy Blog

JULY 24, 2025

This ban commenced in Germany in 2002, followed by the United Kingdom that same year, and then Switzerland in 2003. "In Europe, for example, various countries enacted a ban on the sale, distribution and medicinal use of kava following several incidents of reported liver toxicity among individuals who regularly consumed kava [ 7 , 8 ].

Regulations

New Drug Approvals

JULY 18, 2025

24] Roche held one 2002 patent, CNA028118480A (CN1516590A), over the broader class of 4′-substituted nucleotides. Geniune holds one patent related to the drug: the original 2007 patent on the entire class of 2′-fluorine-4′-substituted nucleotides, purchased from Zhengzhou University. [8]

RNA

LifeSciVC

NOVEMBER 17, 2023

We then shift to the venture ecosystem and the broader capital markets, highlighting the parallels with twenty years ago, post the genomics bubble in 2002-2003. As usual, we close with a brief update on Atlas itself.

Science

Drug Target Review

NOVEMBER 1, 2023

2002 Jul 22;158(2):227–33. 2002 Feb;66(2–3):101–21. Umezu-Goto M, Kishi Y, Taira A, et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. The Journal of Cell Biology. Valdés-Rives SA, González-Arenas A. Mediators of Inflammation. 2017;2017:1–15. Nat Commun.

Clinical Trials

SCIENMAG: Medicine & Health

JULY 18, 2023

Between 2002 and 2014, between 12% and 20% of UK adult smokers […]

Marketing

Drug Target Review

APRIL 4, 2024

In the years 1998-2002, he served as member of the board of directors at Carlsson Research. In 2002, he was appointed Chief Scientific Officer at Carlsson Research and in 2006 he was appointed CEO. Between 1995 and 2000, he was managing research collaborations between the University and Pharma Industry partners.

Disease

LifeSciVC

JANUARY 12, 2024

It’s also not feeling like the nuclear winter of 2002-2003 either, where venture-backed biotech was starving. Stepping back from the specifics of these data, the venture funding market for private biotech companies feels like it’s returned to a healthier place than the bubblicious euphoria of a few years ago.

Marketing

Drug Target Review

NOVEMBER 24, 2023

2002 September 15 [2023 November 21]; 62(18):5381-5. Eurekalert [Internet]. 2023 November 17 [2023 November 20]. Available from: [link] 3 Baluk P, McDonald DM. Significance of Blood Vessel Leakiness in Cancer. Cancer Research. Available from: [link]

Immune Response

Drug Target Review

NOVEMBER 20, 2023

Distinguishing tumours Dr Anand Kumar of the Athinoula A Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH) said: “Our lab has been studying fluorescence lifetime imaging since 2002, but this is the first time that anyone has combined it with tumour imaging and injectable dyes in humans.

FDA Approval

Eye on FDA

AUGUST 2, 2022

By 2002, the number had dropped to 28, reviving somewhat by the end of that decade when it reached 52 in 2010. But when it comes to enforcement things have changed greatly over the years. In 1998, there were 156 letters issued in a single year.

Pharmaceutical Companies

Common Sense for Drug Policy Blog

OCTOBER 4, 2024

Changes in Criteria for Identifying Cannabis Dependence: From DSM-IV to DSM-V "Based on NSDUH estimates, rates of cannabis abuse and dependence remained relatively stable from 2002 to 2019, with the highest rates of abuse and dependence among young adults (aged 18–25) (Figure 3-27).

Engineering

Common Sense for Drug Policy Blog

DECEMBER 28, 2023

The former NHSDA was redesigned in 1999, and other changes were made to the survey in 2002, which may have increased the sensitivity of the NSDUH for identifying people who are binge drinking and alcohol dependent. Differences in the prevalence of alcohol dependence between the current study and the 2002 study in New Mexico (10.7%

Production

The Pharma Data

OCTOBER 16, 2020

from Kosin University Gospel Hospital in South Korea, and colleagues used data from 732,199 individuals who had undergone a national health check-up in 2002 to 2003. FRIDAY, Oct. 16, 2020 — Use of aspirin , metformin , and statins is associated with a lower risk for lung cancer mortality, according to a study published online Sept.

Hospitals

The Pharma Data

MARCH 23, 2021

In the interview, Mr. Reinhardt was asked about the company’s $678 million settlement last year with the United States Government, which resolved claims that during the time period from 2002 to 2011, Novartis used certain promotional programs as a way improperly to induce doctors to prescribe Novartis products, in violation of US anti-kickback law.

Doctors

Broad Institute

OCTOBER 17, 2023

She’d always had an interest in genetics research and moved to Boston in 2002 to work for a genetics-focused startup. Deik received her bachelor's degree in botany from Connecticut College and immediately went to work at International Paper, a paper manufacturing company, where she engineered trees to grow faster.

Research

Common Sense for Drug Policy Blog

DECEMBER 15, 2023

It showed little change in its usage levels through 2002. Ketamine Use by Students in the US "Prevalence of past-12 month use of ketamine (another “club drug”) among 12th grade students has been below 2% for the past decade and in 2022 stood at 1.2%. This “club drug” was added to the survey in 2000. Since then use has declined in all grades.

Drugs

Common Sense for Drug Policy Blog

JUNE 4, 2023

One study demonstrated that the homeless use SCRA to escape from the realities of the streets and provide relief from physical and mental health conditions, similar to the motivations for using cannabis, heroin and crack cocaine within the population (Fountain and Howes 2002 ; Link, 2014 ; Peacock et al., Van Calster, P.

Common Sense for Drug Policy Blog

AUGUST 22, 2023

The risk environments framework provides a theoretical foundation for doing so ( Rhodes, 2002 ), emphasising the importance of enabling contexts and resources in advancing harm reduction ( Duff, 2009 , 2011 ). 2023 ; Piatkowski et al., 2022 , 2023 a).

Drugs

NIH Director's Blog: Drug Development

OCTOBER 11, 2022

2002, 41 (14), 2596–2599. [3] 2002, 67 (9), 3057–3064. [4] Rostovtsev VV, Green LG, Fokin VV, Sharpless KB. 3] Peptidotriazoles on solid phase: [1,2,3]-Triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. Tornøe CW, Sengeløv H, Meldal M.

Research

The Pharma Data

JANUARY 21, 2021

In this study, researchers analyzed records for 5,417 adults and children diagnosed with lupus since 2002 at all U.S. The condition can be fatal, and often causes debilitating bouts of fatigue and pain that prevent nearly half of adult patients from working. Previous estimates of lupus were larger but unverified.

Clinical Trials

The Pharma Data

NOVEMBER 10, 2020

The new study included thousands of British children born between 2000 and 2002. They were assessed at ages 3, 5, 7, 11 and 14 using questionnaires about their strengths and difficulties, which had been completed by parents and teachers.

Hospitals

FDA Law Blog: Drug Discovery

JUNE 11, 2023

Between 2002 and 2019, there were 768 products with pediatric labeling changes under BPCA and/or PREA. However, given FDA’s prior announced policy, it is somewhat surprising that only 16% of pediatric labeling changes pursuant to BPCA and/or PREA between 2002 and 2019 were conducted under both the BPCA and PREA.

FDA

The Pharma Data

NOVEMBER 23, 2020

In addition to his roles at Legend, Zhang has also been the chairman, an executive director and CEO of GenScript, which he cofounded in 2002. Legend said it did not anticipate any charges being brought against the company in relation to the arrest. Zhang had served as the chairman of board of directors of Legend Biotech since 2015.

Government

Common Sense for Drug Policy Blog

JUNE 4, 2023

Although this bill in 2002 was never passed, it was reintroduced in US Congress the following year as the Illicit Drug Anti-Proliferation Act which made it illegal to knowingly lease, rent, or use a space for the purpose of distributing or using controlled substances.

Drugs

FDA Law Blog: Biosimilars

NOVEMBER 9, 2023

The requirement for prior notice originates in the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (the Bioterrorism Act). “Prior notice” informs FDA about the products it can expect to be offered for import into the country. food supply and other food-related emergencies.

Regulations

The Pharma Data

NOVEMBER 18, 2020

is a Taiwan biopharmaceutical company that was established in 2002. The above poster presentations will be available online at www.obipharma.com on November 23, 2020. About OBI Pharma. OBI Pharma, Inc.,

Vaccine

Drug Target Review

FEBRUARY 29, 2024

Dr Van Laar has been researching neuroprotective approaches for Parkinson’s disease since 2002, with her research efforts focused on mechanisms of neurodegenerative diseases and the therapeutic potential of gene therapy.

Therapies

Drug Target Review

MAY 11, 2023

Elsevier Current Trends; 2002 [cited 2023Apr25]. References: David Bertwistle, Abstract Mutations in the BRCA1 and BRCA2 genes confer a high risk of breast cancer development [Internet]. Current Opinion in Genetics & Development. Available from: [link] RAD51 gene family structure and function – annual reviews [Internet].

DNA

Agency IQ

MAY 28, 2024

law as the Medical Devices Regulation 2002 (UK MDR 2002). The access route used will depend upon the device risk classification under the UK MDR 2002, which MHRA goes on to note might differ from the classification in the CRC that issued the device approval. s work towards a new medical device regulatory framework The U.K.

International

Common Sense for Drug Policy Blog

DECEMBER 20, 2023

By giving people who use drugs the opportunity to consume in a calm, hygienic and supervised environment DCRs also aim to reduce harms resulting from the broader ‘risk environment’ that socially marginalised or excluded groups may be exposed to as a consequence of multiple interacting physical, social, economic and policy factors (Rhodes, 2002). "In

Drugs

PLOS: DNA Science

JUNE 1, 2023

DEB has been a candidate for a gene therapy since 2002. RDEB is inherited from two carrier parents. A dominant form – DDEB – is less severe, blistering the hands, feet, knees, and elbows. This DNA Science post from 2018 traces the history of the efforts.

FDA Approval

Drug Target Review

JUNE 19, 2024

From 2002 until 2004, Mr Culley was Director of Business Development and Marketing for Immusol, Inc. Mr Culley served from 2007 to 2010 as Mast’s Chief Business Officer and Senior Vice President, from 2006 to 2007 as Mast’s Senior Vice President, Business Development, and from 2004 to 2006 as Mast’s Vice President, Business Development.

Therapies

Common Sense for Drug Policy Blog

SEPTEMBER 12, 2020

In April 2002, Kevin debated DEA Administrator Asa Hutchinson at a conference hosted by Rice University's James Baker Institute. He spoke at nationally recognized legal seminars and testified before Congress on drug related issues. 2005 interview with Kevin on the syndicated radio program Cultural Baggage is available.

Doctors

PLOS: DNA Science

SEPTEMBER 28, 2023

Assembling panels of SNPs and associating them with health conditions began in 2002 with the International HapMap Project , shortly after the first human genomes were sequenced. A few hundred thousand or even a million SNPs is a shortcut, less to analyze than the 3.2 billion base pairs of a genome.

Disease

Perficient: Drug Development

JUNE 14, 2023

In 2002, Perficient acquired the small technology company I was working for in Chicago. How do you impact the company’s culture of collaboration? What does a typical day or project look like? John and his wife, Merri I have been with Perficient for 19 years.

Science

The Premier Consulting Blog

AUGUST 21, 2024

August 2021: [link] Pharmaceutical Regulations in Japan: Drug Development: [link] [link] [link] Stability conditions for WHO Member States by Region, March 2021: [link]

Clinical Development